FAP and Hepatic fibrosis: In the model of CCl4-induced liver fibrosis, the amount and expression of type 1 and 3 collagens, as well as osteopontin, decreases with the introduction of the FAPα enzymatic activity inhibitor during the progression of fibrosis, but not during the remodeling stage [104].